The winners in business have shifted markedly in the past decade—and the keys to success are likely to be very different again in ten years’ time. How should leaders prepare their companies to thrive in a rapidly evolving landscape? What will it take to win the '20s?

André Kronimus is The Boston Consulting Group’s global topic leader for corporate development in health care (biopharma and medtech) and chemicals. He is a member of the firm’s global Health Care and Corporate Development practice leadership teams and coleads BCG's Corporate Finance Task Force in Europe. He is also a core member of the Industrial Goods practice, with a particular focus on the chemical and agrochemical industry.

Since joining BCG in 2003, André has worked extensively in mergers and acquisitions in the US, Europe, and Asia, on both the buy and sell sides.

He has also worked with numerous clients on a wide range of corporate development topics, including corporate and portfolio strategy, growth strategy, and industry landscaping, plus finance organization and processes, primarily in the biopharma, medtech, and chemical sectors. André frequently advises private-equity funds on due diligence and portfolios.

Before joining BCG, André worked as a research and teaching assistant in finance at the WHU Otto Beisheim School of Management.

Boston Consulting Group is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity / expression, national origin, protected veteran status, or any other characteristic protected under federal, state or local law, where applicable, and those with criminal histories will be considered in a manner consistent with applicable state and local laws.

BCG uses cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Privacy Policy. By continuing to use this site, or by clicking "I agree," you consent to the use of cookies.